Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests. The imaging test highlights aggressive prostate cancer cells, reducing the ...

—Findings from a recent study suggest that management of prostate cancer has improved in the last 2 decades, including a lower frequency of pathologic grade group 1 prostatectomies. The number of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Windsong Radiology Group President Dr. Raja Cheruvu became ...

A multi-institutional clinical trial showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches. A ...

Most patients with prostate cancer undergoing treatment experience complications associated with worse quality of life or new health risks. Prostate cancer surgery and radiation therapy are associated ...

A BREAKTHROUGH IN PROSTATE CANCER TREATMENT IS NOW AVAILABLE RIGHT HERE IN CINCINNATI, AND ONE LOCAL HOSPITAL AND DOCTOR ARE UTILIZING IT WITH EARLY SUCCESS. WLWT NEWS FIVE’S MEGAN MITCHELL SPOKE WITH ...

A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of ...

DEAR DR. ROACH: Regarding your recent column about prostate cancer, could you please clarify a statement that has created some concern and confusion for me? The statement is: “Screening begins to have ...

The MarketWatch News Department was not involved in the creation of this content. GRENOBLE, France and PRINCETON, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Koelis, SAS ("Koelis" or the "Company", ...